Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Carbohydrate or lignin – or derivative
Patent
1997-06-04
1998-11-24
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Carbohydrate or lignin, or derivative
514570, 514629, 514781, 424690, 424693, A61K 4700, A61K 3119, A61K 3116, A61K 3308
Patent
active
058407685
ABSTRACT:
Novel pharmaceutical suspensions comprising a pharmaceutically active ingredient suspended in aqueous media with a suspending agent comprising attrited microcrystalline cellulose coprocessed and at least partially surface coated with a calcium sodium alginate salt complex barrier dispersant and readily dispersible and hydratable dry formulations thereof are described and exemplified.
REFERENCES:
patent: 4427681 (1984-01-01), Munshi
patent: 5366742 (1994-11-01), Tuason, Jr. et al.
patent: 5605712 (1997-02-01), Bertrand et al.
Colliopoulos John A.
Dell Sheila M.
Reilly, Jr. William J.
Selinger Edward
Andersen Robert L.
FMC Corporation
Henley III Raymond
Prestia Paul F.
LandOfFree
MCC: alginate pharmaceutical suspensions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with MCC: alginate pharmaceutical suspensions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MCC: alginate pharmaceutical suspensions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702709